Abstract |
The clinical efficacy of oral pyronaridine was assessed in 22 symptomatic Cameroonian patients infected with Plasmodium ovale or Plasmodium malariae. All patients were cured on or before day 4. In vitro drug assays confirmed the sensitivity of P. ovale and P. malariae isolates to chloroquine and pyronaridine.
|
Authors | P Ringwald, J Bickii, A Same-Ekobo, L K Basco |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 41
Issue 10
Pg. 2317-9
(Oct 1997)
ISSN: 0066-4804 [Print] United States |
PMID | 9333075
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimalarials
- Naphthyridines
- Tablets, Enteric-Coated
- pyronaridine
|
Topics |
- Adolescent
- Adult
- Animals
- Antimalarials
(administration & dosage, therapeutic use)
- Child
- Female
- Humans
- Malaria
(drug therapy, parasitology)
- Male
- Naphthyridines
(administration & dosage, therapeutic use)
- Plasmodium
- Plasmodium malariae
- Tablets, Enteric-Coated
|